Skip to content

The effectiveness of Animal Assisted Therapy in adults with an Autism Spectrum Disorder

Explorative study towards the effects of Animal Assisted Therapy in adults with an Autism Spectrum Disorder: A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24083
Enrollment
72
Registered
2016-06-09
Start date
2014-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder Animal Assisted Therapy Dogs Stress

Interventions

The AAT program exists of ten weekly one-on-one sessions, with a duration of 60 minutes per session. The therapist follows a strict therapy protocol. The therapy dog that is present in the therapy ses

Sponsors

GGZ oost Brabant: Mcs. Carolien Wijker Open University: Prof. Dr. M. J. Enders-Slegers and Dr. T. Verheggen Autismekenniscentrum: Dr. A. A. Spek
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: A primary diagnosis within the autism spectrum is required for participation in the study. The participants must be diagnosed through, a semi-structured interview based on the DSM-V criteria and the ADI-R Age between 18-60. WAIS-IV score > 80. Participants suffer from stress (PSS > 20), and overal psychological distress (SCL-90 > 133).

Exclusion criteria

Exclusion criteria: Psychosis High Suicide risk Fear of dogs Medicin that involves the ingredient cortison Involving other treatment than AAT during the 20 weeks of research

Design outcomes

Primary

MeasureTime frame
Stress (self-reported, salivary measurements, heart rate variablity measurements) Psychological distress (self reported) Self-confidence (self reported) Autistic traits (self reported)

Secondary

MeasureTime frame
Video analysis

Contacts

Public ContactCarolien Wijker

Gezondheidslaan 65

c.wijker@ggzoostbrabant.nl0412-848325

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)